Details for 2017168533

Up to date per 02.04.2026

Actions

Title / Product Name

N-[2-{4-[6-AMINO-5-(2,4-DIFLUOROBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]-3,5-DIFLUOROPHENYL}ETHYL]-L-ALANIN UND DER TERBUTYLESTER DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017168533

EP Publication Number

3222616

E-Number

1155728

Language

PCT Number

Publication Date

27.09.2017 A

17.07.2019 B1

Registration Date

17.07.2019

AT Publication Date

15.08.2019

Application Date

15.10.2013

Registration Number

Priorities

17.10.2012

201218640

16.04.2013

201306881

IPC

C07D 213/73 20060101AFI20180416BHEP

Maximum Duration of Protection

15.10.2033

Owner

MACROPHAGE PHARMA LIMITEDSt. Stephens House Arthur Road Windsor, Berkshire SL4 1RUGB

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

PINTAT, Stéphanec/o Chroma Therapeutics Ltd Crown House 27 Old Gloucester Street London WC1N 3AXGB

DAVIES, Stephen, Johnc/o Chroma Therapeutics Ltd Crown House 27 Old Gloucester Street London WC1N 3AXGB

MOFFAT, David, Festus, Charlesc/o Chroma Therapeutics Ltd Crown House 27 Old Gloucester Street London WC1N 3AXGB